Markets remained almost unchanged as Janet Yellen concluded her two-day Congressional testimony before the House Financial Services Committee on Wednesday. In her testimony, Yellen failed to provide enough clues to investors regarding rate hike. Meanwhile, decline in Apple’s shares and dismal earnings results from Hewlett-Packard dragged down technology shares. However, encouraging earnings results from retailers including TJX and Dollar Tree […]
A calm trading session ended with the Dow and S&P 500 slipping into the red as another decline in oil prices affected energy shares. Though these two benchmarks eased off their record highs, the indices were able to erode a chunk of their initial losses following a late-afternoon rally. However, a rally in Apple’s shares propelled Nasdaq to its ninth-straight […]
Markets ended in negative territory for second-consecutive day as intensified concern about Greece’s debt negotiations continued to hurt investor sentiment. Moreover, China’s disappointing trade data also had a negative impact on benchmarks on Monday. However, rise in oil prices limited some of the day’s losses.For a look at the issues currently facing the markets, make sure to read today’s Ahead […]
SummaryGold-stock trading volume is high and growing, revealing much trader conviction behind the strong early-year rallies in gold and silver stocks.
The higher the volume underlying any particular move, the greater its strength and staying power. And the volume in the gold juniors, which are slaved to sentiment, is incredible.
Since trading volume generally grows as uplegs mature, seeing such high volume […]
Rise in oil prices, new deals and upbeat quarterly results helped benchmarks settle in the green on Thursday. While rise in crude oil prices fueled gains in material and energy shares, Pfizer’s plan to acquire Hospira boosted healthcare stocks. Encouraging earnings results from O’Reilly Automotive and Estée Lauder Cos also added to the bullish sentiment. Meanwhile, investors shrugged off discouraging […]
Benchmarks ended Monday’s volatile trading session with solid gains after a rally in oil prices boosted energy shares. An offer from Greece’s finance minister to end the standoff with its international creditors over the country’s debt was also welcomed by investors. Monday’s solid gains came in after the S&P 500 and the Dow posted their biggest monthly loss in almost […]
The new BioShares exchange traded funds offer exposure into small and mid-sized biotech stocks in what portends to be a big year in the sector.See original here:New Biotech ETFs Offer Exposure to Smaller Players in Hot SectorTagged as: amgn, bbc, big-year, biotech, etfs, exchange-traded, Finance, funds-offer, ibb, mid-sized-biotech, Personal Finance, sector, video: markets, Youtube
New Biotech ETFs Offer Exposure to […]
After neglecting my writing for some time the New Year is as good as any to begin the practice gain. Upon reviewing 2014 I’ve decided to drop a few things from my tool box while replacing them with some fresher ideas that I’ve been working on. The first wrench that I plan to use more frequently is using sectors through […]
Benchmarks hit another record high on Friday as investors continued to cheer encouraging economic scenario on the domestic front. However, the trading volume remained low as most of investors were enjoying extended Christmas holiday. The Dow registered 38th record high and the S&P 500 posted 52nd record close on Friday, while the Nasdaq finished at the highest since Mar 2000. […]
Brian RobinsWhat a difference a year makes. The downturn in mining stocks from 2013 saw hot money flow into the biotech sector. But after some spectacular research failures, sentiment soured, leaving the sector firmly in the shadows for much of 2014 so that even the surge in biotech stocks globally bypassed the local players.Alchemia, QRx Pharma and Prana were all […]